• Summit Therapeutics average return on equity for 2023 was -518.94, a 418.32% decline from 2022.
• Summit Therapeutics average return on equity for 2022 was -100.12, a 4.18% increase from 2021.
• Summit Therapeutics average return on equity for 2021 was -104.49, a 13.32% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.